Interleukins are low molecular weight proteins produced by leukocytes that bind to cell surface receptors and act in an autocrine and/or paracrine fashion. These secreted factors modify the cell differentiation program (survival, proliferation, maturation, induction of or protection from apoptosis) of the target cells to which they bind. As such, interleukins impact on diverse biological processes: tissue growth and repair, hematopoietic homeostasis, and at multiple levels of the host defense against pathogens. It is therefore not surprising that the rather generic designation 'interleukin' does not refer to a homogeneous family of proteins, but instead to groups of proteins that adopt different threedimensional structures, bind to distinct classes of receptors, and initiate unique signal transduction pathways. Our discussion of interleukins will be structured according to the two main classes of receptors to which they bind: the type I and type II cytokine receptor families and the IL-1R/TLR (interleukin-1 receptor/ Toll-like receptor) superfamily.
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Type I and II cytokine receptor families Type I cytokine receptors are transmembrane proteins with four conserved cysteine residues and a Trp-Ser-X-Trp-Ser (WSXWS) motif in their extracellular domain, and a cytoplasmic tail containing consensus motifs ('boxes' 1 and 2) involved in signal transduction. The type II cytokine receptors are related but lack the extracellular WSXWS motif (Table 1) . Ligands for these receptors belong to a family characterized by the presence of four α α helices. One predominant characteristic of the type I and II cytokine receptor superfamily is the utilization of shared cytokine receptor subunits -a single receptor chain may participate in the generation of the functional receptor complex for multiple different ligands. As such, the superfamily can be subdivided into receptors sharing the common β β chain, the common γ γ chain, the gp130 molecule, the IL-20Rβ β chain and the IL-22Rα α chain (see Table  1 ). In addition, a number of receptor chains are shared by two different ligand-binding receptor complexes: the IL-4Rα α, the IL-7Rα α, the IL-12Rβ β1, the IL-10Rβ β and the IL-20Rα α chain.
Receptor subunit oligomerization plays an essential role in signaling via the type I and II cytokine receptors. The activation of multiple, distinct intracellular cascades has been documented following type I and II cytokine receptor oligomerization, including the MAPK (mitogen-activated protein kinase, also known as ERK for extracellular-signal-regulated kinase) cascade, the JAK/STAT pathway (Janus kinase/signal transducer and activator of transcription), and the PI3-K (phosphoinositide 3-kinase) cascade. The JAK/STAT pathway appears uniquely coupled to type I and II cytokine receptor signaling, and has been the subject of considerable analysis: the current model is depicted in Figure 1 . Homodimerization, heterodimerization or heterotrimerization of receptor chains in the presence of ligand (Table 1) 
